ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹14 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹14 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | -17.53 | |
| Mar2025 | ₹15 Cr | -7.59 | |
| Mar2024 | ₹16 Cr | 34.17 | |
| Mar2023 | ₹12 Cr | -17.53 | |
| Mar2022 | ₹14 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹412.6 Cr | 4.5% | 5% | -21.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 4.5% |
5% |
-21.9% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses